Immunobiotics and the probiotic evolution

FEMS Immunology and Medical Microbiology

Volumn 38, Issue 1, 2003, Pages 9-12

  Clancy, Robert ^a  

^a ROYAL NEWCASTLE HOSPITAL   (Australia)

Author keywords

Common mucosal system; Immunobiotic; Immunotherapy; Probiotic

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; CANDIDA ALBICANS; CLOSTRIDIUM DIFFICILE; CYTOKINE RELEASE; DENDRITIC CELL; DIARRHEA; ECZEMA; FEMALE GENITAL SYSTEM; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; HUMAN; IMMUNOBIOLOGY; INTESTINE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PHAGOCYTOSIS; PRIORITY JOURNAL; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE; URINARY TRACT INFECTION;

EID: 0141587261     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00147-0     Document Type: Review

References (28)

1. Fuller R. A review: probiotics in man and animals. J. Appl. Bacteriol. 66:1989;365-378.
2. Guarner F., Schaafsma G.J. Probiotics. Int. J. Food Microbiol. 39:1998;237-238.
3. Macfarlane G.T., Cummings J.H. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? Br. Med. J. 318:1999;999-1003.
4. Dunne C., Murphy L., Flynn S., et al. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie van Leeuwenhoek. 76:1999;279-292.
5. Colombel J.F., Cortot A., Neut C., Romond C. Yoghurt with Bifidobacterium longum reduces crythromycin-induced gastrointestinal effects. Lancet. 2:1987;43.
6. Wold Agnes E. Immune effects of probiotics. Scand. J. Nutr. 45:2001;76-85.
7. Clancy R.L., Pang G., Dunkley M., Taylor D., Cripps A. Acute on chronic bronchitis: A model of mucosal immunology. Immunol. Cell Biol. 73:1995;414-417.
8. D'Ostiani C.F., Del Ser G., Bacci A., et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans: implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 191:2000;1661-1678.
9. Kadowaki N., Ho S., Antonenko A., et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194:2001;863-869.
10. Hessle C., Andersson B., Wold A.E. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect. Immun. 68:2000;3581.
11. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168:2002;171-178.
12. Roos K., Hakansson E.G., Holm S. Effect of recolonisation with 'interfering' α streptococci on recurrences of acute and secretory otitis media in children: randomized placebo controlled trial. Br. Med. J. 322:2001;210.
13. Gorbach S.L., Chang T.W., Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet. 2:1987;1519.
14. Andersson H., Asp N.-G., Bruce A., et al. Health effects of probiotics and probiotics. A literature review on human studies. Scand. J. Nutr. 45:2001;58-75.
15. Isolauri E., Juntunen M., Saxilin M., Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. 20:1995;333-336.
16. Reid G., Bruce A.W., Fraser N., et al. Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 30:2001;49-52.
17. Gionchetti P., Rizzello F., Venturi A., et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology. 119:2000;305-309.
18. Armuzzi A., Cremonini F., Bartolozzi F., et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment. Pharmacol. Ther. 15:2001;163-169.
19. Kalliomaki M., Salminen S., Arvilommi H., et al. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet. 357:2001;1076-1079.
20. Clancy, R., Pang, G., Yu, D. et al. (2003) A framework for understanding management of mucosal dysregulation using Lactobacillus acidophilus (LAVRI-1). Allergy Clin. Immunol. Int., in print.
21. Elahi S., Pang G., Clancy R., Ashman R.B. Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect. Immun. 68:2000;5771-5777.
22. Elahi S., Pang G., Clancy R. Development of surrogate markers for oral immunisation against Candida albicans. Vaccine. 3526:2002;1-7.
23. Reid G., Beuerman D., Heinemann C., Bruce A.W. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol. Med. Microbiol. 32:2001;37-41.
24. Sudo N., Sawamura S., Tanaka K., et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159:1997;1739-1745.
25. Kano H., Kaneko T., Kaminogawa S. Oral intake of Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 prevents collagen-induced arthritis in mice. J. Food Prot. 65:2002;153-160.
26. Sly P., Holt P. Etiological factors of atopic disease in the respiratory tract. Mucosal Immunol. Update. 7:1999;13-14.
27. Bjorksten B., Naaber P., Sepp E., Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy. 29:1999;342-346.
28. Borody T., Ren Z., Pang G., Clancy R. Impaired host immunity contributes to Helicobacter pylori eradication failure. Am. J. Gastroenterol. 97:2002;3032-3036.